CNXU Conexeu Sciences Inc. Insider Trading

Director Lynn Sebastian Purcell bought 202,500 shares of CNXU at $0.80 for $162,000 amid recent IPO (22 trading days), raising holdings 8.0% to 2.73M shares.

Director Lynn Sebastian Purcell purchased 202,500 shares at $0.80 on 2026-06-18, 22 trading days after CNXU's recent listing, with the stock now trading at $10.55 as of 2026-06-23. This $162,000 acquisition increased his non-derivative holdings by 8.0% to 2,734,240 shares, while his derivative holdings through warrants total 1,250,000 shares. The company is unprofitable (net income: $-2,304,283.00) with a market cap of $282,300,381.50, suggesting the director's purchase reflects conviction in early-stage equity value despite current losses. The substantial share price appreciation from transaction price to current price, combined with an insider accumulation early in the public life of the company, may signal confidence in the business trajectory.

10% owner Onepointtwo Capital Ventures LLC acquired 422,500 shares of CXNU at $0.80 for $338,000.00

Onepointtwo Capital Ventures LLC, a 10% shareholder, purchased 422,500 shares at $0.80 per share on 2026-05-12, increasing its post-transaction holdings to 1,047,500 shares. This represents a material addition to an already substantial ownership position, with the $338,000.00 acquisition reflecting either a scheduled or discretionary capital commitment at the current market price. The transaction's significance lies in the filer's existing ownership concentration: as a 10% stakeholder, this insider's investment activity carries visibility to other shareholders regarding conviction at this price level.

Director Purcell Lynn Sebastian buys 422,500 shares of CXNU at $0.80; holdings reach 2,531,740 shares

Purcell Lynn Sebastian, a director at Conexeu Sciences Inc., purchased 422,500 shares at $0.80 per share, bringing his total holdings to 2,531,740 shares. This represents a substantial absolute commitment of capital in a single discretionary transaction by a board-level insider. The director's post-transaction stake of 2,531,740 shares signals meaningful alignment with company fortunes at the current valuation.